ZA200803212B - Method for determining preeclampsia risk - Google Patents

Method for determining preeclampsia risk

Info

Publication number
ZA200803212B
ZA200803212B ZA200803212A ZA200803212A ZA200803212B ZA 200803212 B ZA200803212 B ZA 200803212B ZA 200803212 A ZA200803212 A ZA 200803212A ZA 200803212 A ZA200803212 A ZA 200803212A ZA 200803212 B ZA200803212 B ZA 200803212B
Authority
ZA
South Africa
Prior art keywords
preeclampsia risk
determining
determining preeclampsia
risk
preeclampsia
Prior art date
Application number
ZA200803212A
Other languages
English (en)
Inventor
Hamutal Meiri
Marei Sammar
Renate Hillermann
Original Assignee
Diagnostic Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostic Technologies Ltd filed Critical Diagnostic Technologies Ltd
Publication of ZA200803212B publication Critical patent/ZA200803212B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ZA200803212A 2007-02-01 2008-04-11 Method for determining preeclampsia risk ZA200803212B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89870707P 2007-02-01 2007-02-01

Publications (1)

Publication Number Publication Date
ZA200803212B true ZA200803212B (en) 2009-12-30

Family

ID=39111486

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200803212A ZA200803212B (en) 2007-02-01 2008-04-11 Method for determining preeclampsia risk

Country Status (6)

Country Link
US (1) US20080187929A1 (xx)
EP (1) EP2038431A1 (xx)
JP (1) JP2010517525A (xx)
CN (1) CN101627131A (xx)
WO (1) WO2008093318A1 (xx)
ZA (1) ZA200803212B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2609110A1 (en) * 2010-08-27 2013-07-03 Universitätsklinikum Münster Means and methods for the detection of a predisposition of a female subject to recurrent pregnancy loss (rpl), preeclampsia (pe) and/or fetal growth restriction (fgr)
IN2014CN04326A (xx) * 2011-12-15 2015-09-04 Pronota Nv
RU2478966C1 (ru) * 2012-01-24 2013-04-10 Олег Валентинович Радьков Способ оценки тяжести преэклампсии
CA2990000A1 (en) 2015-06-19 2016-12-22 Sera Prognostics, Inc. Biomarker pairs for predicting preterm birth
CA3073192A1 (en) 2017-08-18 2019-02-21 Sera Prognostics, Inc Pregnancy clock proteins for predicting due date and time to birth

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198366A (en) * 1986-03-23 1993-03-30 Technion Research & Development Foundation Ltd. Method for the detection of pregnancy disorders
IL123098A0 (en) * 1998-01-29 1998-09-24 Diagnostic Technologies Ltd Placental protein 13
IL129273A (en) * 1999-03-30 2003-10-31 Diagnostic Technologies Ltd Monoclonal antibody to placental protein 13 and immunoassay and kit using said antibody
WO2004021012A2 (en) * 2002-08-29 2004-03-11 Diagnostic Technologies Ltd. Method of diagnosis of pregnancy-related complications
EP1979749A1 (en) * 2006-02-02 2008-10-15 Diagnostic Technologies Ltd. A method for determining the effectiveness of a treatment for preeclampsia

Also Published As

Publication number Publication date
JP2010517525A (ja) 2010-05-27
WO2008093318A1 (en) 2008-08-07
US20080187929A1 (en) 2008-08-07
CN101627131A (zh) 2010-01-13
EP2038431A1 (en) 2009-03-25

Similar Documents

Publication Publication Date Title
IL202689A0 (en) Method for perception measurement
ZA201001753B (en) Method for consumer-dispenser interactions
GB0707096D0 (en) Method
GB2446670C (en) Inspection method
EP2171169A4 (en) METHOD
GB2462829B (en) Measurement method
EP2147309A4 (en) METHODS OF DETECTING PRECLAMPSY
GB0624462D0 (en) Method for determining gentoxicity
EP2306771A4 (en) METHOD FOR MEASURING ADJUSTING AREAS
EP2270480A4 (en) ANALYTICAL METHOD
EP2455751A4 (en) METHOD FOR QUANTIFYING PROTEIN
GB0703366D0 (en) Method
EP2275814A4 (en) A-BETA-Oligomer-MEASURING METHOD
EP2085764A4 (en) METHOD FOR DETERMINING AGGLUTINATION
GB0710321D0 (en) Method
GB0708960D0 (en) Method
ZA200803212B (en) Method for determining preeclampsia risk
HUE043508T2 (hu) Eljárás hálózati paraméterek meghatározására
PL2040227T3 (pl) Sposób testowania monet
GB0612669D0 (en) Biomarkers for preeclampsia
EP2116611A4 (en) METHOD OF MEASURING HBA1C
EP2180643A4 (en) INVESTIGATIONS
GB0705321D0 (en) Method
GB0710519D0 (en) Method
GB0710520D0 (en) Method